All In MedTech

Device Trial Radar · NCT03130777

ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent

Multicenter Study of Congenital Pulmonic Valve Dysfunction Studying the SAPIEN 3 THV With the Alterra Adaptive Prestent

Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registry

Status

Active, not recruiting

Enrollment

86

Actual

Start

Aug 22, 2017

Primary completion

Jul 14, 2022

Study completion Jun 2032

Sponsor

Lead sponsor
Edwards LifesciencesPublic (EW)
Sponsor type
Industry
First posted
Apr 26, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) System in subjects with a dysfunctional right ventricular outflow tract/pulmonary valve (RVOT/PV) who are indicated for treatment of pulmonary regurgitation (PR). Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.

Conditions

  • Pulmonary Disease
  • Transcatheter Pulmonary Valve Replacement (TPVR)
  • Tetralogy of Fallot
  • Congenital Heart Disease
  • Pulmonary Regurgitation

Interventions

  • Edwards Alterra Adaptive Prestent with SAPIEN 3 THVDevice

    The Edwards Alterra Adaptive Prestent is designed to reduce the diameter of large irregular RVOTs and provide a circular, semi-rigid landing zone to place an Edwards SAPIEN 3 THV.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Main Cohort: THV DysfunctionTime frame: 6 months
  2. PDS Registry: Acute PDS SuccessTime frame: 24 hours

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • University of California, Los Angeles

    Los Angeles, California

  • University of California, San Francisco

    San Francisco, California

11 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.